← SynDRA
CIPROFIBRATE
SynDRA canonical compound SYN0019791 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | PPARA |
| Mechanism of action | PPAR receptor agonist |
| Indication | hyperlipidemia |
| Disease area | endocrinology |
All known targets
Mechanisms of action (all sources)
- PPAR receptor agonist
- PPARA AGONIST
- Peroxisome proliferator-activated receptor alpha agonist
Drug classes
- Antimetabolites
- Carcinogens
- Hypolipidemic Agents
- Lipid Regulating Agents
- Noxae
- Peroxisome Proliferators
ATC classes
- C10A · LIPID MODIFYING AGENTS, PLAIN
Cross-references
Synonyms
- lipanor
- oroxadin
- Ciprofibrato
- NSC-759617
- WIN-35833
- Modalim
- Ciprofibratum
- Ciprol
- Hiperlipen
- Hyperlipen
- Lipanor
- Oroxadin
- Sanofi Synthelabo brand of ciprofibrate
- Sanofi Winthrop brand of ciprofibrate
- C 0330
- Win-35833
- Ciprofibrato [INN-Spanish]
- Ciprofibratum [INN-Latin]
- Win 35,833
- Ciprofibrate (USAN/INN)
- Ciprofibrate [USAN:BAN:INN]
- 2-(4-(2,2-Dichlorocyclopropyl)phenoxy)2-methylpropanoic acid
- 2-(p-(2,2-Dichlorocyclopropyl)phenoxy)-2-methylpropionic acid
- 2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid
- 2-[p-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid
- 2-{4-[2,2-dichlorocyclopropyl]phenoxy}-2-methylpropanoic acid
- 2-{[4-(2,2-dichlorocyclopropyl)phenyl]oxy}-2-methylpropanoic acid
- 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methylpropanoic acid
- Propanoic acid, 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methyl-
- MFCD00467135
- NSC 759617
- F8252JGO9S
- CHEBI:50867
- Propanoic acid, 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methyl-
- NCGC00164447-01
- SMR000857190
- CCRIS 173
- SR-01000075734
Look up CIPROFIBRATE in the interactive SynDRA portal →